Inhibition of complement action

Details Inhibition of complement action Inhibition of complement action

2006-05-23

2006-05-23

Kerr, Kathleen M. (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S021800, C514S002600, C514S014800, C514S015800

Reexamination Certificate

active

07049282

ABSTRACT:
The present invention relates to a method of blocking biochemical function of the classical complement pathway and thereby preventing immunologic damage in a variety of diseases and conditions including autoimmune diseases.

REFERENCES:
patent: 4753927 (1988-06-01), Hahn
patent: 5726286 (1998-03-01), Alderson et al.
patent: 5731168 (1998-03-01), Carter et al.
patent: 5869286 (1999-02-01), Yao et al.
patent: 6451308 (2002-09-01), Strom et al.
patent: WO 95/30015 (1995-11-01), None
patent: WO 98/31820 (1998-07-01), None
Linton et al, “Complement Activation and Inhibition in Experimental Models of Arthritis”, Molecular Immunology 36:905-914 (1999).
Nielsen et al, “The Role of Complement in the Acquired Immune Response”, Immunology 100:4-12 (2000).
Platt et al, “The Role of Complement in Transplantation”, Molecular Immunology 36:965-971 (1999).

Affiliated with

Also associated with

Rating

Inhibition of complement action does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of complement action, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of complement action will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3626458